{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T06:43:27Z","timestamp":1788417807443,"version":"build-2803163510"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T00:00:00Z","timestamp":1726617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T00:00:00Z","timestamp":1726617600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National Institutes on Aging Northern California Institute for Research and Education","award":["grant R24AG064025"],"award-info":[{"award-number":["grant R24AG064025"]}]},{"name":"National Institutes on Aging Northern California Institute for Research and Education","award":["subaward STE2196-13(USDeN)"],"award-info":[{"award-number":["subaward STE2196-13(USDeN)"]}]},{"name":"National Institutes on Aging Northern California Institute for Research and Education","award":["grant R24AG064025"],"award-info":[{"award-number":["grant R24AG064025"]}]},{"name":"National Institutes on Aging Northern California Institute for Research and Education","award":["subaward 5K23-AG058788"],"award-info":[{"award-number":["subaward 5K23-AG058788"]}]},{"name":"Veteran Affairs Health Services Research and Development Service","award":["RCS 10-39"],"award-info":[{"award-number":["RCS 10-39"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s40266-024-01144-7","type":"journal-article","created":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T20:16:14Z","timestamp":1726690574000},"page":"809-819","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Fall Outcomes in Older Adults Following Benzodiazepine\/Z-Drug Discontinuation: A Retrospective Cohort Study in an Academic Health System"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6445-5376","authenticated-orcid":false,"given":"Nicole J.","family":"Schindler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay","family":"Zepel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew L.","family":"Maciejewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan N.","family":"Hastings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sascha","family":"Dublin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ladia","family":"Albertson-Junkans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliessa M.","family":"Pavon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,18]]},"reference":[{"issue":"5","key":"1144_CR1","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1001\/jamainternmed.2015.0324","volume":"175","author":"IA Scott","year":"2015","unstructured":"Scott IA, Hilmer SN, Reeve E, Potter K, Le Couteur D, Rigby D, et al. Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Intern Med. 2015;175(5):827\u201334.","journal-title":"JAMA Intern Med"},{"key":"1144_CR2","unstructured":"Organization WH. Medication Without Harm\u2014WHO Global Patient Safety Challenge. In: Organization WH, editor. Geneva: World Health Organization 2017."},{"issue":"3","key":"1144_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0118991","volume":"10","author":"JJ Sutherland","year":"2015","unstructured":"Sutherland JJ, Daly TM, Liu X, Goldstein K, Johnston JA, Ryan TP. Co-prescription trends in a large cohort of subjects predict substantial drug-drug interactions. PLoS ONE. 2015;10(3): e0118991.","journal-title":"PLoS ONE"},{"issue":"4","key":"1144_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/sdata.2017.167","volume":"31","author":"KJ Quinn","year":"2017","unstructured":"Quinn KJ, Shah NH. A dataset quantifying polypharmacy in the United States. Sci Data. 2017;31(4): 170167.","journal-title":"Sci Data."},{"issue":"3","key":"1144_CR5","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/bcp.12975","volume":"82","author":"AT Page","year":"2016","unstructured":"Page AT, Clifford RM, Potter K, Schwartz D, Etherton-Beer CD. The feasibility and effect of deprescribing in older adults on mortality and health: a systematic review and meta-analysis. Br J Clin Pharmacol. 2016;82(3):583\u2013623.","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"1144_CR6","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1093\/ageing\/afz109","volume":"48","author":"HJ Woodford","year":"2019","unstructured":"Woodford HJ, Fisher J. New horizons in deprescribing for older people. Age Ageing. 2019;48(6):768\u201375.","journal-title":"Age Ageing"},{"issue":"12","key":"1144_CR7","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1111\/jgs.13153","volume":"62","author":"TR Fried","year":"2014","unstructured":"Fried TR, O\u2019Leary J, Towle V, Goldstein MK, Trentalange M, Martin DK. Health outcomes associated with polypharmacy in community-dwelling older adults: a systematic review. J Am Geriatr Soc. 2014;62(12):2261\u201372.","journal-title":"J Am Geriatr Soc"},{"key":"1144_CR8","unstructured":"National Center for Injury Prevention and Control. Web-based Injury Statistics Query and Reporting System [cited; Available from:"},{"issue":"37","key":"1144_CR9","first-page":"993","volume":"65","author":"G Bergen","year":"2016","unstructured":"Bergen G, Stevens M, Burns E. Falls and fall injuries among adults aged \u2265 65 years- United States, 2014. Weekly. 2016;65(37):993\u20138.","journal-title":"Weekly"},{"issue":"1","key":"1144_CR10","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.archger.2013.07.006","volume":"58","author":"M Stenhagen","year":"2014","unstructured":"Stenhagen M, Ekstrom H, Nordell E, Elmstahl S. Accidental falls, health-related quality of life and life satisfaction: a prospective study of the general elderly population. Arch Gerontol Geriatr. 2014;58(1):95\u2013100.","journal-title":"Arch Gerontol Geriatr"},{"issue":"9","key":"1144_CR11","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1345\/aph.1Q689","volume":"46","author":"KN Freeland","year":"2012","unstructured":"Freeland KN, Thompson AN, Zhao Y, Leal JE, Mauldin PD, Moran WP. Medication use and associated risk of falling in a geriatric outpatient population. Ann Pharmacother. 2012;46(9):1188\u201392.","journal-title":"Ann Pharmacother"},{"issue":"7526","key":"1144_CR12","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1136\/bmj.38623.768588.47","volume":"331","author":"J Glass","year":"2005","unstructured":"Glass J, Lanct\u00f4t KL, Herrmann N, et al. Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. BMJ. 2005;331(7526):1169.","journal-title":"BMJ"},{"issue":"10","key":"1144_CR13","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1016\/j.ajem.2017.04.023","volume":"35","author":"CN Kaufmann","year":"2017","unstructured":"Kaufmann CN, Spira AP, Alexander GC, Rutkow L, Mojtabai R. Emergency department visits involving benzodiazepines and non-benzodiazepine receptor agonists. Am J Emerg Med. 2017;35(10):1414\u20139.","journal-title":"Am J Emerg Med"},{"key":"1144_CR14","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h2698","volume":"350","author":"TW Park","year":"2015","unstructured":"Park TW, Saitz R, Ganoczy D, Ilgen MA, Bohnert AS. Benzodiazepine prescribing patterns and deaths from drug overdose among US veterans receiving opioid analgesics: case-cohort study. BMJ. 2015;350: h2698.","journal-title":"BMJ"},{"issue":"4","key":"1144_CR15","doi-asserted-by":"publisher","first-page":"594","DOI":"10.3390\/neurolint13040059","volume":"13","author":"AN Edinoff","year":"2021","unstructured":"Edinoff AN, Nix CA, Hollier J, Sagrera CE, Delacroix BM, Abubakar T, Cornett EM, Kaye AM, Kaye AD. Benzodiazepines: uses, dangers, and clinical considerations. Neurol Int. 2021;13(4):594\u2013607.","journal-title":"Neurol Int"},{"issue":"11","key":"1144_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-046916","volume":"11","author":"J Brandt","year":"2021","unstructured":"Brandt J, Janzen D, Alessi-Severini S, Singer A, Chateau D, Enns M, Leong C. Risk of long-term benzodiazepine and Z-drug use following the first prescription among community-dwelling adults with anxiety\/mood and sleep disorders: a retrospective cohort study. BMJ Open. 2021;11(11): e046916.","journal-title":"BMJ Open"},{"key":"1144_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.eclinm.2024.102507","volume":"70","author":"J Brandt","year":"2024","unstructured":"Brandt J, Bressi J, Le ML, et al. Prescribing and deprescribing guidance for benzodiazepine and benzodiazepine receptor agonist use in adults with depression, anxiety, and insomnia: an international scoping review. eClinicalMedicine. 2024;70:1\u201316.","journal-title":"eClinicalMedicine"},{"issue":"6","key":"1144_CR18","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1002\/gps.5494","volume":"36","author":"MG Borda","year":"2021","unstructured":"Borda MG, Jaramillo-Jimenez A, Oesterhus R, Santacruz JM, Tovar-Rios DA, Soennesyn H, Cano-Gutierrez CA, Vik-Mo AO, Aarsland D. Benzodiazepines and antidepressants: effects on cognitive and functional decline in Alzheimer\u2019s disease and Lewy body dementia. Int J Geriatr Psychiatry. 2021;36(6):917\u201325.","journal-title":"Int J Geriatr Psychiatry"},{"key":"1144_CR19","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.maturitas.2017.04.002","volume":"101","author":"MJ D\u00edaz-Guti\u00e9rrez","year":"2017","unstructured":"D\u00edaz-Guti\u00e9rrez MJ, Mart\u00ednez-Cengotitabengoa M, S\u00e1ez de Adana E, Cano AI, Mart\u00ednez-Cengotitabengoa MT, Besga A, Segarra R, Gonz\u00e1lez-Pinto A. Relationship between the use of benzodiazepines and falls in older adults: a systematic review. Maturitas. 2017;101:17\u201322.","journal-title":"Maturitas"},{"issue":"4","key":"1144_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0174730","volume":"12","author":"K Donnelly","year":"2017","unstructured":"Donnelly K, Bracchi R, Hewitt J, Routledge PA, Carter B. Benzodiazepines, Z-drugs and the risk of hip fracture: a systematic review and meta-analysis. PLoS ONE. 2017;12(4): e0174730.","journal-title":"PLoS ONE"},{"issue":"10","key":"1144_CR21","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.1007\/s00198-016-3605-8","volume":"27","author":"SM Park","year":"2016","unstructured":"Park SM, Ryu J, Lee DR, Shin D, Yun JM, Lee J. Zolpidem use and risk of fractures: a systematic review and meta-analysis. Osteoporos Int. 2016;27(10):2935\u201344.","journal-title":"Osteoporos Int"},{"issue":"4","key":"1144_CR22","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s40268-017-0207-7","volume":"17","author":"J Brandt","year":"2017","unstructured":"Brandt J, Leong C. Benzodiazepines and Z-Drugs: an updated review of major adverse outcomes reported on in epidemiologic research. Drugs R D. 2017;17(4):493\u2013507.","journal-title":"Drugs R D."},{"issue":"4","key":"1144_CR23","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1093\/ijnp\/pyz007","volume":"22","author":"F Schifano","year":"2019","unstructured":"Schifano F, Chiappini S, Corkery JM, Guirguis A. An insight into Z-drug abuse and dependence: an examination of reports to the European Medicines Agency Database of Suspected Adverse Drug Reactions. Int J Neuropsychopharmacol. 2019;22(4):270\u20137.","journal-title":"Int J Neuropsychopharmacol"},{"issue":"4","key":"1144_CR24","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s41999-022-00731-4","volume":"14","author":"A Capiau","year":"2023","unstructured":"Capiau A, Huys L, van Poelgeest E, van der Velde N, Petrovic M, Somers A. Therapeutic dilemmas with benzodiazepines and Z-drugs: insomnia and anxiety disorders versus increased fall risk: a clinical review. Eur Geriatr Med. 2023;14(4):697\u2013708.","journal-title":"Eur Geriatr Med"},{"issue":"2","key":"1144_CR25","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-035978","volume":"11","author":"J Lee","year":"2021","unstructured":"Lee J, Negm A, Peters R, Wong EKC, Holbrook A. Deprescribing fall-risk increasing drugs (FRIDs) for the prevention of falls and fall-related complications: a systematic review and meta-analysis. BMJ Open. 2021;11(2): e035978.","journal-title":"BMJ Open"},{"issue":"1","key":"1144_CR26","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1186\/s12877-021-02208-8","volume":"21","author":"K Ibrahim","year":"2021","unstructured":"Ibrahim K, Cox NJ, Stevenson JM, Lim S, Fraser SDS, Roberts HC. A systematic review of the evidence for deprescribing interventions among older people living with frailty. BMC Geriatr. 2021;21(1):258.","journal-title":"BMC Geriatr"},{"issue":"6","key":"1144_CR27","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1111\/bcp.12732","volume":"80","author":"E Reeve","year":"2015","unstructured":"Reeve E, Gnjidic D, Long J, Hilmer S. A systematic review of the emerging de fi nition of \u201cdeprescribing\u201d with network analysis: implications for future research and clinical practice. Br J Clin Pharmacol. 2015;80(6):1254\u201368.","journal-title":"Br J Clin Pharmacol"},{"issue":"21","key":"1144_CR28","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1001\/jama.296.21.joc60162","volume":"296","author":"JK Lee","year":"2006","unstructured":"Lee JK, Grace KA, Taylor AJ. Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial. JAMA. 2006;296(21):2563\u201371.","journal-title":"JAMA"},{"key":"1144_CR29","first-page":"336","volume":"32","author":"T Nguyen","year":"2023","unstructured":"Nguyen T, Dublin S, Albertson-Junkans L, et al. Defining key deprescribing measures from electronic health data: Learnings from a multisite data harmonization project. Pharmacoepidemiol Drug Saf. 2023;32:336\u20137.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"18","key":"1144_CR30","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1001\/jama.2018.16131","volume":"320","author":"P Martin","year":"2018","unstructured":"Martin P, Tamblyn R, Benedetti A, Ahmed S, Tannenbaum C. Effect of a pharmacist-led educational intervention on inappropriate medication prescriptions in older adults: the D-PRESCRIBE Randomized Clinical Trial. JAMA. 2018;320(18):1889\u201398.","journal-title":"JAMA"},{"issue":"1","key":"1144_CR31","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jpain.2018.08.003","volume":"20","author":"M Von Korff","year":"2019","unstructured":"Von Korff M, Saunders K, Dublin S, Walker RL, Thakral M, Sherman KJ, Ludman EJ, Hansen RN, Parchman M, Shortreed SM. Impact of chronic opioid therapy risk reduction initiatives on opioid overdose. J Pain. 2019;20(1):108\u201317.","journal-title":"J Pain"},{"issue":"1","key":"1144_CR32","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/pds.4678","volume":"28","author":"S Dublin","year":"2019","unstructured":"Dublin S, Walker RL, Shortreed SM, Ludman EJ, Sherman KJ, Hansen RN, Thakral M, Saunders K, Parchman ML, Von Korff M. Impact of initiatives to reduce prescription opioid risks on medically attended injuries in people using chronic opioid therapy. Pharmacoepidemiol Drug Saf. 2019;28(1):90\u20136.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"1144_CR33","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jpain.2015.10.002","volume":"17","author":"M Von Korff","year":"2016","unstructured":"Von Korff M, Dublin S, Walker RL, Parchman M, Shortreed SM, Hansen RN, Saunders K. The impact of opioid risk reduction initiatives on high-dose opioid prescribing for patients on chronic opioid therapy. J Pain. 2016;17(1):101\u201310.","journal-title":"J Pain"},{"issue":"2","key":"1144_CR34","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/anae.12120","volume":"68","author":"AM Ho","year":"2013","unstructured":"Ho AM, Dion PW, Ng CS, Karmakar MK. Understanding immortal time bias in observational cohort studies. Anaesthesia. 2013;68(2):126\u201330.","journal-title":"Anaesthesia"},{"issue":"2","key":"1144_CR35","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1111\/jgs.16233","volume":"68","author":"AM Elias","year":"2020","unstructured":"Elias AM, Ogunwale AN, Pepin MJ, Bailey JC, Adams AD, Colon-Emeric CS, et al. High prevalence of fall-related medication use in older veterans at risk for falls. J Am Geriatr Soc. 2020;68(2):438\u20139.","journal-title":"J Am Geriatr Soc"},{"issue":"8","key":"1144_CR36","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.9679","volume":"2","author":"L Min","year":"2019","unstructured":"Min L, Tinetti M, Langa KM, Ha J, Alexander N, Hoffman GJ. Measurement of fall injury with health care system data and assessment of inclusiveness and validity of measurement models. JAMA Netw Open. 2019;2(8): e199679.","journal-title":"JAMA Netw Open"},{"issue":"9","key":"1144_CR37","doi-asserted-by":"publisher","first-page":"afac205","DOI":"10.1093\/ageing\/afac205","volume":"51","author":"M Montero-Odasso","year":"2022","unstructured":"Montero-Odasso M, van der Velde N, Martin FC, et al. Task Force on Global Guidelines for Falls in Older Adults. World guidelines for falls prevention and management for older adults: a global initiative. Age Ageing. 2022;51(9):afac205.","journal-title":"Age Ageing"},{"key":"1144_CR38","doi-asserted-by":"publisher","first-page":"5146378","DOI":"10.1155\/2017\/5146378","volume":"2017","author":"Y Paliwal","year":"2017","unstructured":"Paliwal Y, Slattum PW, Ratliff SM. Chronic health conditions as a risk factor for falls among the community-dwelling US older adults: a zero-inflated regression modeling approach. Biomed Res Int. 2017;2017:5146378.","journal-title":"Biomed Res Int"},{"issue":"7","key":"1144_CR39","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1111\/j.1532-5415.1999.tb03843.x","volume":"47","author":"AJ Campbell","year":"1999","unstructured":"Campbell AJ, Robertson MC, Gardner MM, Norton RN, Buchner DM. Psychotropic medication withdrawal and a home-based exercise program to prevent falls: a randomized, controlled trial. J Am Geriatr Soc. 1999;47(7):850\u20133.","journal-title":"J Am Geriatr Soc"},{"key":"1144_CR40","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.japh.2015.11.001","volume":"56","author":"DA Mott","year":"2016","unstructured":"Mott DA, Martin B, Breslow R, et al. Impact of a medication therapy management intervention targeting medications associated with falling: results of a pilot study. J Am Pharm Assoc. 2016;56:22\u20138.","journal-title":"J Am Pharm Assoc"},{"issue":"1","key":"1144_CR41","first-page":"142","volume":"46","author":"NDA Boy\u00e9","year":"2017","unstructured":"Boy\u00e9 NDA, van der Velde N, de Vries OJ, et al. Effectiveness of medication withdrawal in older fallers: results from the improving medication prescribing to reduce risk of falls (IMPROveFALL) trial. Age Ageing. 2017;46(1):142\u20136.","journal-title":"Age Ageing"},{"issue":"6","key":"1144_CR42","doi-asserted-by":"publisher","first-page":"658","DOI":"10.7861\/clinmedicine.14-6-658","volume":"14","author":"CG Swift","year":"2014","unstructured":"Swift CG. Iliffe S (2014) Assessment and prevention of falls in older people - concise guidance. Clin Med. 2014;14(6):658\u201362.","journal-title":"Clin Med"},{"issue":"6","key":"1144_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0285584","volume":"18","author":"AD Ritvo","year":"2023","unstructured":"Ritvo AD, Foster DE, Huff C, Finlayson AR, Silvernail B, Martin PR. Long-term consequences of benzodiazepine-induced neurological dysfunction: a survey. PLoS ONE. 2023;18(6): e0285584.","journal-title":"PLoS ONE"},{"issue":"3","key":"1144_CR44","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/s41593-022-01013-9","volume":"25","author":"Y Shi","year":"2022","unstructured":"Shi Y, Cui M, Ochs K, Brendel M, Strubing FL, Briel N, et al. Long-term diazepam treatment enhances microglial spine engulfment and impairs cognitive performance via the mitochondrial 18 kDa translocator protein (TSPO). Nat Neurosci. 2022;25(3):317\u201329.","journal-title":"Nat Neurosci"},{"issue":"1","key":"1144_CR45","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/s41398-021-01718-8","volume":"11","author":"L Carton","year":"2021","unstructured":"Carton L, Niot C, Kyheng M, Petrault M, Laloux C, Potey C, et al. Lack of direct involvement of a diazepam long-term treatment in the occurrence of irreversible cognitive impairment: a pre-clinical approach. Transl Psychiatry. 2021;11(1):612.","journal-title":"Transl Psychiatry"},{"key":"1144_CR46","doi-asserted-by":"publisher","first-page":"204512532211455","DOI":"10.1177\/20451253221145561","volume":"13","author":"C Huff","year":"2023","unstructured":"Huff C, Finlayson AJR, Foster DE, Martin PR. Enduring neurological sequelae of benzodiazepine use: an Internet survey. Ther Adv Psychopharmacol. 2023;13:20451253221145560.","journal-title":"Ther Adv Psychopharmacol."},{"issue":"7","key":"1144_CR47","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1007\/s00228-014-1684-z","volume":"70","author":"MS Bakken","year":"2014","unstructured":"Bakken MS, Engeland A, Engesaeter LB, Ranhoff AH, Hunskaar S, Ruths S. Risk of hip fracture among older people using anxiolytic and hypnotic drugs: a nationwide prospective cohort study. Eur J Clin Pharmacol. 2014;70(7):873\u201380.","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"1144_CR48","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1001\/jama.2009.2024","volume":"303","author":"ME Tinetti","year":"2010","unstructured":"Tinetti ME, Kumar C. The patient who falls: \u201cIt\u2019s always a trade-off.\u201d JAMA. 2010;303(3):258\u201366.","journal-title":"JAMA"},{"issue":"2","key":"1144_CR49","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1007\/s11096-022-01494-5","volume":"45","author":"M Alharthi","year":"2022","unstructured":"Alharthi M, Wright D, Scott S, Blacklock J. Terms used to describe and define activities undertaken as a result of the medication review process: do they require standardisation? A systematic review. Int J Clin Pharm. 2022;45(2):304\u201319.","journal-title":"Int J Clin Pharm"},{"issue":"4","key":"1144_CR50","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s40266-014-0157-5","volume":"31","author":"O Dalleur","year":"2014","unstructured":"Dalleur O, Boland B, Losseau C, Henrard S, Wouters D, Speybroeck N, et al. Reduction of potentially inappropriate medications using the STOPP criteria in frail older inpatients: a randomised controlled study. Drugs Aging. 2014;31(4):291\u20138.","journal-title":"Drugs Aging"},{"issue":"1","key":"1144_CR51","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s11096-019-00784-9","volume":"41","author":"N Ailabouni","year":"2019","unstructured":"Ailabouni N, Mangin D, Nishtala PS. DEFEAT-polypharmacy: deprescribing anticholinergic and sedative medicines feasibility trial in residential aged care facilities. Int J Clin Pharm. 2019;41(1):167\u201378.","journal-title":"Int J Clin Pharm"},{"issue":"6","key":"1144_CR52","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1001\/jamainternmed.2014.949","volume":"174","author":"C Tannenbaum","year":"2014","unstructured":"Tannenbaum C, Martin P, Tamblyn R, Benedetti A, Ahmed S. Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education: the EMPOWER cluster randomized trial. JAMA Intern Med. 2014;174(6):890\u20138.","journal-title":"JAMA Intern Med"},{"issue":"1","key":"1144_CR53","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/NCQ.0000000000000412","volume":"35","author":"H Brom","year":"2020","unstructured":"Brom H, Brooks Carthon JM, Ikeaba U, Chittams J. Leveraging electronic health records and machine learning to tailor nursing care for patients at high risk for readmissions. J Nurs Care Qual. 2020;35(1):27\u201333.","journal-title":"J Nurs Care Qual"},{"issue":"186","key":"1144_CR54","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.drugalcdep.2018.01.008","volume":"1","author":"LT Wu","year":"2018","unstructured":"Wu LT, Ghitza UE, Zhu H, Spratt S, Swartz M, Mannelli P. Substance use disorders and medical comorbidities among high-need, high-risk patients with diabetes. Drug Alcohol Depend. 2018;1(186):86\u201393.","journal-title":"Drug Alcohol Depend"},{"issue":"8","key":"1144_CR55","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.eurpsy.2015.09.003","volume":"30","author":"TA Kurko","year":"2015","unstructured":"Kurko TA, Saastamoinen LK, T\u00e4hk\u00e4p\u00e4\u00e4 S, Tuulio-Henriksson A, Taiminen T, Tiihonen J, Airaksinen MS, Hietala J. Long-term use of benzodiazepines: definitions, prevalence and usage patterns-a systematic review of register-based studies. Eur Psychiatry. 2015;30(8):1037\u201347.","journal-title":"Eur Psychiatry"},{"issue":"1\u20132","key":"1144_CR56","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.drugalcdep.2009.04.017","volume":"104","author":"SY Fang","year":"2009","unstructured":"Fang SY, Chen CY, Chang IS, Wu EC, Chang CM, Lin KM. Predictors of the incidence and discontinuation of long-term use of benzodiazepines: a population-based study. Drug Alcohol Depend. 2009;104(1\u20132):140\u20136.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"1144_CR57","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s12877-023-03878-2","volume":"23","author":"MA Mohammed","year":"2023","unstructured":"Mohammed MA, Harrison J, Milosavljevic A, Chan AHY. Attitude towards deprescribing and its association with frailty and complexity of medication regimen: a survey of older inpatients in a district health board in New Zealand. BMC Geriatr. 2023;23(1):166.","journal-title":"BMC Geriatr"},{"issue":"1","key":"1144_CR58","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12913-019-3995-3","volume":"19","author":"EE Vasilevskis","year":"2019","unstructured":"Vasilevskis EE, Shah AS, Hollingsworth EK, Shotwell MS, Mixon AS, Bell SP, Kripalani S, Schnelle JF, Simmons SF, Shed-MEDS Team. A patient-centered deprescribing intervention for hospitalized older patients with polypharmacy: rationale and design of the Shed-MEDS randomized controlled trial. BMC Health Serv Res. 2019;19(1):165.","journal-title":"BMC Health Serv Res"},{"issue":"14","key":"1144_CR59","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1471-2318-14-40","volume":"27","author":"V Milos","year":"2014","unstructured":"Milos V, Bondesson \u00c5, Magnusson M, Jakobsson U, Westerlund T, Midl\u00f6v P. Fall risk-increasing drugs and falls: a cross-sectional study among elderly patients in primary care. BMC Geriatr. 2014;27(14):40.","journal-title":"BMC Geriatr"},{"issue":"10","key":"1144_CR60","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-016358","volume":"7","author":"NN Dhalwani","year":"2017","unstructured":"Dhalwani NN, Fahami R, Sathanapally H, Seidu S, Davies MJ, Khunti K. Association between polypharmacy and falls in older adults: a longitudinal study from England. BMJ Open. 2017;7(10):e016358.","journal-title":"BMJ Open"},{"issue":"11","key":"1144_CR61","doi-asserted-by":"publisher","first-page":"1067243","DOI":"10.3389\/fpubh.2023.1067243","volume":"2","author":"M Pernes","year":"2023","unstructured":"Pernes M, Agostinho I, Bernardes RA, Belo Fernandes J, Baixinho CL. Documenting fall episodes: a scoping review. Front Public Health. 2023;2(11):1067243.","journal-title":"Front Public Health"}],"container-title":["Drugs & Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-024-01144-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40266-024-01144-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-024-01144-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T15:18:22Z","timestamp":1729005502000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40266-024-01144-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,18]]},"references-count":61,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["1144"],"URL":"https:\/\/doi.org\/10.1007\/s40266-024-01144-7","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,18]]},"assertion":[{"value":"14 August 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This work was supported by the National Institutes on Aging Northern California Institute for Research and Education grant R24AG064025, subaward STE2196-13(USDeN) (MM, SNH, LZ, AC, JMP); 5K23-AG058788 (J.M.P.) and the Veteran Affairs Health Services Research and Development Service RCS 10-39 (M.M.). The funding agencies had no role in the design or conduct of the study; collection, analysis, or interpretation of the data; or preparation, review, or approval of the manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors declare no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest:"}},{"value":"The datasets used and\/or analyzed for this study are available from the corresponding author upon reasonable request. Restrictions apply to the availability of raw data due to the sensitive nature of the data.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data and Material"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The codes used for analysis during the current study are available from the corresponding author upon reasonable request","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"All authors contributed to the study conception and design. Material preparation, data collection, and analysis were performed by N.S., L.Z., and J.P.; the first draft of the manuscript was written by N.S. and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Contributions"}}]}}